Patent · US Expired

Beta 2 adrenergic polymorphism detection

US6593092B2 · kind B2 · utility

1Cited by
10References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2001
Grant dateJul 15, 2003
Priority date
Expiry dateDec 2, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Nucleic acid sequences are provided that are useful as amplification primers, hybridization probes, and as a portion of molecular beacon probes for amplifying and detecting polymorphisms of the &bgr;2 adrenergic receptor gene, compositions and kits incorporating the same, and methods employing the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.